$UPB SEC Filings

Filed On	Filing
17 Sep 2026	Form 4: Deykin Aaron, Chief Medical Officer Sold 895 shares ($4.91K)
17 Sep 2026	Form 4: Sutherland Everett Rand, Director Sold 2,095 shares ($11.5K)
17 Sep 2026	Form 4: Houghton Adam, Chief Business Officer Sold 700 shares ($3.84K)
17 Sep 2026	Form 4: Gray Michael, CFO and COO Sold 853 shares ($4.68K)
17 Sep 2026	Form 4: Ambrose Allison, General Counsel Sold 485 shares ($2.66K)
01 Sep 2026	8-K: Regulation FD Disclosure; Other Events
12 Aug 2026	SCHEDULE 13G/A
11 Aug 2026	8-K: Results of Operations and Financial Condition
11 Aug 2026	10-Q
30 Jul 2026	SCHEDULE 13G
17 Jun 2026	Form 4: Gray Michael, CFO and COO Sold 853 shares ($5.2K)
17 Jun 2026	Form 4: Sutherland Everett Rand, Director Sold 2,095 shares ($12.8K)
17 Jun 2026	Form 4: Houghton Adam, Chief Business Officer Sold 700 shares ($4.27K)
17 Jun 2026	Form 4: Deykin Aaron, Chief Medical Officer Sold 895 shares ($5.46K)
17 Jun 2026	Form 4: Ambrose Allison, General Counsel Sold 477 shares ($2.91K)
11 Jun 2026	Form 4: Ruddy Marcella K., Director Granted 17,096 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Renaud Ronald C Jr, Director Granted 17,096 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Fleming Harold Edward, Director Granted 17,096 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Beckman Daniella, Director Granted 17,096 Stock Option (Right to Buy)
11 Jun 2026	Form 4: Ratcliffe Liam, Director Granted 17,096 Stock Option (Right to Buy)

Comments